Xin Wang

4.5k total citations
227 papers, 2.9k citations indexed

About

Xin Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xin Wang has authored 227 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 48 papers in Molecular Biology. Recurrent topics in Xin Wang's work include Breast Cancer Treatment Studies (23 papers), Esophageal Cancer Research and Treatment (23 papers) and Gastric Cancer Management and Outcomes (21 papers). Xin Wang is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Esophageal Cancer Research and Treatment (23 papers) and Gastric Cancer Management and Outcomes (21 papers). Xin Wang collaborates with scholars based in China, United States and United Kingdom. Xin Wang's co-authors include Pankaj Gupta, Won Park, Charles A. Mebus, Thomas Stock, Bradley J. Bloom, Ying Wu, Jing Xiao, Bing Sun, Carol Braunschweig and David M. Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xin Wang

213 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Wang China 26 1.0k 643 556 487 369 227 2.9k
Feng Gao China 32 1.1k 1.0× 956 1.5× 497 0.9× 357 0.7× 652 1.8× 138 3.7k
Xuan Liu China 38 2.0k 1.9× 1.2k 1.8× 526 0.9× 785 1.6× 342 0.9× 218 4.2k
Yong Wang China 35 1.8k 1.8× 401 0.6× 887 1.6× 729 1.5× 354 1.0× 205 3.9k
Yu Fan China 31 682 0.7× 425 0.7× 285 0.5× 579 1.2× 307 0.8× 146 2.9k
Zsuzsanna K. Zsengellér United States 39 1.8k 1.7× 654 1.0× 480 0.9× 276 0.6× 494 1.3× 96 5.6k
Vita Dolžan Slovenia 33 1.3k 1.2× 362 0.6× 394 0.7× 268 0.6× 239 0.6× 210 3.7k
Stefania Rossi Italy 34 1.1k 1.0× 630 1.0× 273 0.5× 189 0.4× 329 0.9× 123 3.7k
Hong Yan China 29 1.1k 1.1× 464 0.7× 178 0.3× 387 0.8× 158 0.4× 139 2.4k
Meng‐Yu Wu Taiwan 18 842 0.8× 194 0.3× 248 0.4× 316 0.6× 432 1.2× 112 2.6k

Countries citing papers authored by Xin Wang

Since Specialization
Citations

This map shows the geographic impact of Xin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Wang more than expected).

Fields of papers citing papers by Xin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Wang. The network helps show where Xin Wang may publish in the future.

Co-authorship network of co-authors of Xin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Wang. A scholar is included among the top collaborators of Xin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Wang. Xin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jie, et al.. (2025). Minimally invasive treatment of fungal keratitis with voriconazole microneedle corneal patch. European Journal of Pharmaceutics and Biopharmaceutics. 211. 114717–114717. 5 indexed citations
2.
Zhang, Meifang, Wenwei Han, Dalian Liu, et al.. (2024). Enzymatically extracted ulvans restrict viruses via STING signaling and type I interferon after cellular entry. Carbohydrate Polymers. 348(Pt A). 122778–122778. 3 indexed citations
3.
4.
Yu, Nuo, Jiao Li, Jianjun Qin, et al.. (2024). Efficacy and safety of the combination of tisleizumab with chemoradiotherapy in oligorecurrence esophageal squamous cell carcinoma: A prospective phase II study.. Journal of Clinical Oncology. 42(16_suppl). 4057–4057. 1 indexed citations
5.
6.
Luo, Xu, Xiangbing Deng, Wenjian Meng, et al.. (2023). Predicting Rectal Cancer Response to Total Neoadjuvant Treatment Using an Artificial Intelligence Model Based on Magnetic Resonance Imaging and Clinical Data. Technology in Cancer Research & Treatment. 22. 2223928355–2223928355. 5 indexed citations
7.
Chen, Yuping, et al.. (2023). Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia. Schizophrenia Research. 264. 81–86. 4 indexed citations
8.
Dai, Yining, et al.. (2023). Quantitative analysis of choroidal alterations in thyroid eye disease using swept-source OCT. Frontiers in Physics. 11. 1 indexed citations
9.
10.
11.
Wang, Xin, Shuping Zhou, Minghao Li, et al.. (2023). CD83+ B cells alleviate uveitis through inhibiting DCs by sCD83. Immunology. 170(1). 134–153. 5 indexed citations
12.
Liu, Wei, Yi Zeng, Xin Wang, et al.. (2023). JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte‐derived leptin. Cancer Communications. 43(10). 1117–1142. 12 indexed citations
13.
Wang, Hong, Yanjie Li, Lin Lei, et al.. (2023). Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis. Cancer Medicine. 13(1). e6787–e6787. 9 indexed citations
14.
Wang, Wenyan, Xin Wang, Xiang Wang, Jiaqi Liu, & Pin Zhang. (2019). Nomogram for predicting axillary lymph node pathological complete response in node-positive breast cancer patients after neoadjuvant chemotherapy.. Journal of Clinical Oncology. 37(15_suppl). e12090–e12090. 1 indexed citations
15.
Zou, Xiaonong, et al.. (2017). [Changing Epidemic of Lung Cancer & Tobacco and Situation of Tobacco Control 
in China].. SHILAP Revista de lepidopterología. 20(8). 505–510. 15 indexed citations
16.
Wang, Xin, Yuan Tang, Hua Ren, et al.. (2016). A preliminary study of efficacy of preoperative concurrent chemoradiotherapy for locally advanced gastric cancer. Zhonghua fangshe zhongliuxue zazhi. 25(11). 1204–1208.
17.
Xu, Liming, Lujun Zhao, Xiuli Chen, et al.. (2015). Comparison of efficacy of different fractionation schedules in radiotherapy for extensive-stage small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 24(5). 488–492. 1 indexed citations
18.
Feng, Yanru, Jing Jin, Xin Wang, et al.. (2014). Comparison of concurrent chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone in stage II/III rectal cancer patients after radical operation. Zhonghua fangshe zhongliuxue zazhi. 23(3). 199–204. 2 indexed citations
19.
Pan, Yunbao, Qingxiu Zhang, Ling Tian, et al.. (2012). Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma. Cancer Research. 72(7). 1890–1900. 61 indexed citations
20.
Su, Xiao‐Dong, Hao Long, Peng Lin, et al.. (2010). Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer. Chinese Journal of Cancer. 29(5). 538–544. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Gao Breakdown of academic impact, for papers by Xuan Liu Breakdown of academic impact, for papers by Yong Wang Breakdown of academic impact, for papers by Yu Fan Breakdown of academic impact, for papers by Zsuzsanna K. Zsengellér Breakdown of academic impact, for papers by Vita Dolžan Breakdown of academic impact, for papers by Stefania Rossi Breakdown of academic impact, for papers by Hong Yan Breakdown of academic impact, for papers by Meng‐Yu Wu
Rankless by CCL
2026